Optimizing ribavirin dose is critical for sustained viral response in patients with thalassemia major treated for chronic hepatitis C

Authors
Publication date
1 January 2012
Publisher
WILEY-BLACKWELL

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    University of Queensland eSpace

    redirect
    oaioai:espace.library.uq.edu.au:U...
    Last time updated on 04/08/2016